Abound Wealth Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$163 Hold
4
– – ﹤0.01% 1223
2026
Q2
$210 Sell
4
-1
-20% -$39 ﹤0.01% 1104
2026
Q1
$177 Sell
5
-3
-38% -$93 ﹤0.01% 1265
2025
Q4
$224 Hold
8
– – ﹤0.01% 1135
2025
Q3
$240 Hold
8
– – ﹤0.01% 1065
2025
Q2
$229 Hold
8
– – ﹤0.01% 994
2025
Q1
$265 Sell
8
-2
-20% -$65 ﹤0.01% 900
2024
Q4
$288 Hold
10
– – ﹤0.01% 904
2024
Q3
$280 Hold
10
– – ﹤0.01% 994
2024
Q2
$241 Sell
10
-10
-50% -$245 ﹤0.01% 1052
2024
Q1
$542 Buy
+20
New +$568 ﹤0.01% 870

Other funds holding ALKS

Abound Wealth Management's ALKS Position: Q3 2026 in Review

Abound Wealth Management held its Alkermes (ALKS) position steady in Q3 2026 at 4 shares worth $163. The position accounts for ﹤0.01% of the portfolio, ranked #1223.

Abound Wealth Management first reported a position in ALKS in Q1 2024 and has held it in 11 quarters since. The position peaked at $542 in Q1 2024. 128 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • Abound Wealth Management held 4 shares of Alkermes worth $163 as of Q3 2026.
  • Abound Wealth Management left its Alkermes share count unchanged in Q3 2026.
  • Alkermes made up ﹤0.01% of Abound Wealth Management's portfolio in Q3 2026, its #1223 holding.
  • Abound Wealth Management first reported a position in Alkermes in Q1 2024 and has held it in 11 quarters since.
  • Abound Wealth Management's Alkermes position peaked at $542 in Q1 2024.
  • 128 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.